← SynDRA
CINTIRORGON
SynDRA canonical compound SYN0039894 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | RORC |
|---|
| Mechanism of action | ROR agonist |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- RORB
- RORA
- NR1I2
- ABL1
- AURKA
- TRIM24
- TDG
- SMUG1
- RXRA
- OGG1
- NTHL1
- NR5A1
- NR4A1
- NR2E1
- NR2C1
- NEIL2
- NEIL1
- MUTYH
- MBD4
- MAPK1
- KCNH2
- HNF4A
- GSK3B
- FGFR3
- CYP3A4
- CYP2D6
- CYP2C19
- CSNK1D
- CDK2
- BRPF1
- BRD4
- UNG
Cross-references
Synonyms
- Lyc-55716
- LYC 55716
- UNII-LPN433P0EA
- LPN433P0EA
- Cintirorgon [INN]
- cintirorgon (proposed INN)
- SCHEMBL18302870
- GTPL10045
- LYC55716
- BCP28882
- EX-A2635
- CS-7496
- compound 32J [WO2016201225A1]
- HY-104037
- 3-[(2S)-6-[3-(difluoromethoxy)-5-fluorophenyl]-4-[3-(trifluoromethyl)phenyl]sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]-2,2-dimethylpropanoic acid
- LYC-55716
- cintirorgonum
- RefChem:126299
- RORg Agonist LYC-55716
- MFCD31544352
- Cintirorgon?
- CINTIRORGON [WHO-DD]
- C27H23F6NO6S
- orb1296278
- SCHEMBL29379832
- WLZ3537
- GLXC-20787
- BDBM50515653
- NSC803601
- NSC-803601
- AC-36326
- DA-65157
- MS-30640
- SY274341
- F78355
- SCHEMBL29493853
- LYC-55716 SODIUM
- T6S6P87405
- NWMACPZNQFABGF-BDQAORGHSA-M
Look up CINTIRORGON in the interactive SynDRA portal →